Targeting EGFR, T790M, ALK, and ROS1 in NSCLC

Access Activity

Overview / Abstract:

Oncology treatment teams are tasked with navigating through a steady increase in the number and complexity of molecular biomarkers that guide treatment decisions. FDA-approved companion tests have expanded testing options and provide uniformity of reporting, yet challenges in the clinical setting and the potential to negatively impact patient outcomes persist. As part of the continuum of care in oncology, there is an increasing demand for genomic testing to guide the course of treatment.
Misinterpretation and over-interpretation of biomarker and genomic tests can be confusing. There is no shortage of targeted agents for the well-established molecular subtypes of non-small cell lung cancer (NSCLC); however, selecting the right agents for the right patients remains a challenge in the community setting. Appropriate evidence-based and quality care will directly affect reimbursement and incentives within the new payment models.

Expiration

Feb 13, 2019

Discipline(s)

Nurse Practitioner , Nursing CNE, Physician CME

Format

Online, Webinar / Webcast / Video

Credits / Hours

AACME - 1.00 AMA PRA Category 1 Credit; ACPE - 1.00 hours (0.1 CEUs); ANCC - 1.1 contact hours; APRN - 1.0 contact hours pharmacology credit

Accreditation

AACME, ACPE, ANCC, APRN

Presenters / Authors / Faculty

Benjamin Levy, MD
Clinical Director of The Sidney Kimmel Cancer Center
Johns Hopkins Medicine at Sibley Hospital
Washington, DC

Activity Specialities / Related Topics

Hematology, Oncology / Cancer / Radiation Therapy

Sponsors / Supporters / Grant Providers

This activity is supported by independent educational grants from AstraZeneca, Genentech, Lilly, and Novartis Pharmaceuticals Corporation. For further information concerning Lilly grant funding visit www.lillygrantoffice.com

Keywords / Search Terms

Rockpointe oncology, hematology, biomarkers, RN, APN, NP, Registered Nurse, Advance Practice Nurse, Nurse Practitioner, Physician, Pharmacy, Pharmacist, Free CME, CME, CE, CME/CE Free CE CME

Access Activity

CORE Higher Education Group, CESearchEngine.com, and our advertising partners do not endorse and do not verify the accuracy of the content in the activities presented on the CESearchEngine.com website or within our mobile apps.CORE Higher Education Group, CESearchEngine.com, and our advertising partners are not responsible for errors, omissions, or misrepresentations contained within activities presented on the CESearchEngine website or within our mobile apps. For complete details, please read the CESearchEngine.com Terms of Service. Site Map